Viewing Study NCT03382561


Ignite Creation Date: 2025-12-24 @ 12:01 PM
Ignite Modification Date: 2025-12-24 @ 12:01 PM
Study NCT ID: NCT03382561
Status: COMPLETED
Last Update Posted: 2025-07-03
First Post: 2017-12-21
Is Possible Gene Therapy: False
Has Adverse Events: True

Brief Title: Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2017-02367
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators